JP2003528852A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003528852A5 JP2003528852A5 JP2001570615A JP2001570615A JP2003528852A5 JP 2003528852 A5 JP2003528852 A5 JP 2003528852A5 JP 2001570615 A JP2001570615 A JP 2001570615A JP 2001570615 A JP2001570615 A JP 2001570615A JP 2003528852 A5 JP2003528852 A5 JP 2003528852A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- alkoxy
- amino
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000000217 alkyl group Chemical group 0.000 description 13
- PIGFYZPCRLYGLF-UHFFFAOYSA-N Aluminum nitride Chemical compound [Al]#N PIGFYZPCRLYGLF-UHFFFAOYSA-N 0.000 description 7
- 125000003545 alkoxy group Chemical group 0.000 description 6
- -1 R 21 Chemical compound 0.000 description 5
- 125000003118 aryl group Chemical group 0.000 description 5
- 125000000753 cycloalkyl group Chemical group 0.000 description 5
- 125000001072 heteroaryl group Chemical group 0.000 description 5
- 125000000623 heterocyclic group Chemical group 0.000 description 5
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 description 3
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- NWBJAUFHPXRBKI-QMMMGPOBSA-N (2r)-2-amino-3-[2-(1-aminoethylideneamino)ethylsulfanyl]-2-methylpropanoic acid Chemical compound CC(=N)NCCSC[C@](C)(N)C(O)=O NWBJAUFHPXRBKI-QMMMGPOBSA-N 0.000 description 1
- ADDDJEDAMMOVRD-QMMMGPOBSA-N (2r)-2-amino-3-[2-(1-aminoethylideneamino)ethylsulfonyl]-2-methylpropanoic acid Chemical compound CC(=N)NCCS(=O)(=O)C[C@](C)(N)C(O)=O ADDDJEDAMMOVRD-QMMMGPOBSA-N 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 125000000304 alkynyl group Chemical group 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19192300P | 2000-03-24 | 2000-03-24 | |
| US60/191,923 | 2000-03-24 | ||
| PCT/US2001/009431 WO2001072702A2 (en) | 2000-03-24 | 2001-03-23 | Amidino compounds useful as nitric oxide synthase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003528852A JP2003528852A (ja) | 2003-09-30 |
| JP2003528852A5 true JP2003528852A5 (enExample) | 2008-05-08 |
| JP4216502B2 JP4216502B2 (ja) | 2009-01-28 |
Family
ID=22707469
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001570616A Expired - Fee Related JP4205340B2 (ja) | 2000-03-24 | 2001-03-23 | 酸化窒素シンターゼ阻害剤として有用なアミジノ化合物およびその塩 |
| JP2001570615A Expired - Fee Related JP4216502B2 (ja) | 2000-03-24 | 2001-03-23 | 酸化窒素シンターゼ阻害剤として有用なアミジノ化合物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001570616A Expired - Fee Related JP4205340B2 (ja) | 2000-03-24 | 2001-03-23 | 酸化窒素シンターゼ阻害剤として有用なアミジノ化合物およびその塩 |
Country Status (21)
| Country | Link |
|---|---|
| US (5) | US6403830B2 (enExample) |
| EP (2) | EP1265859B1 (enExample) |
| JP (2) | JP4205340B2 (enExample) |
| KR (1) | KR100835265B1 (enExample) |
| CN (1) | CN1294117C (enExample) |
| AR (1) | AR033359A1 (enExample) |
| AT (2) | ATE295832T1 (enExample) |
| AU (4) | AU2001249415B2 (enExample) |
| BR (1) | BR0109386A (enExample) |
| CA (2) | CA2402199C (enExample) |
| DE (2) | DE60110902T2 (enExample) |
| DK (2) | DK1265859T3 (enExample) |
| ES (2) | ES2256223T3 (enExample) |
| GE (1) | GEP20094625B (enExample) |
| MX (1) | MXPA02009282A (enExample) |
| MY (1) | MY135721A (enExample) |
| NZ (4) | NZ542734A (enExample) |
| PT (1) | PT1265860E (enExample) |
| TW (1) | TWI294417B (enExample) |
| WO (2) | WO2001072703A1 (enExample) |
| ZA (2) | ZA200206459B (enExample) |
Families Citing this family (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1265859T3 (da) * | 2000-03-24 | 2006-05-01 | Pharmacia Corp | Amidinoforbindelser der er nyttige som nitrogenoxidsyntaseinhibitorer |
| US8022058B2 (en) | 2000-05-10 | 2011-09-20 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the RyR receptors |
| US7718644B2 (en) | 2004-01-22 | 2010-05-18 | The Trustees Of Columbia University In The City Of New York | Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof |
| US7393652B2 (en) | 2000-05-10 | 2008-07-01 | The Trustees Of Columbia University In The City Of New York | Methods for identifying a chemical compound that directly enhances binding of FKBP12.6 to PKA-phosphorylated type 2 ryanodine receptor (RyR2) |
| US7879840B2 (en) | 2005-08-25 | 2011-02-01 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the RyR receptors |
| US7012098B2 (en) * | 2001-03-23 | 2006-03-14 | Pharmacia Corporation | Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers |
| AU2002307217A1 (en) | 2001-03-28 | 2002-10-15 | University Of South Florida | Materials and methods for treatment of cancer and identification of anti-cancer compounds |
| MY137736A (en) * | 2001-04-03 | 2009-03-31 | Pharmacia Corp | Reconstitutable parenteral composition |
| DE10141650C1 (de) | 2001-08-24 | 2002-11-28 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen |
| US20030119826A1 (en) * | 2001-09-24 | 2003-06-26 | Pharmacia Corporation | Neuroprotective treatment methods using selective iNOS inhibitors |
| US20030109522A1 (en) * | 2001-09-24 | 2003-06-12 | Manning Pamela T. | Ophthalmologic treatment methods using selective iNOS inhibitors |
| MXPA04004476A (es) * | 2001-11-13 | 2004-08-11 | Pharmacia Corp | Forma de dosificacion oral de un profarmaco la sulfonamida. |
| CN1652843A (zh) * | 2002-05-16 | 2005-08-10 | 法玛西雅公司 | 使用选择性iNOS抑制剂治疗呼吸系统疾病和病症 |
| US20040087653A1 (en) * | 2002-05-16 | 2004-05-06 | Manning Pamela T. | Methods for the treatment of respiratory diseases and conditions with a selective iNOS inhibitor and a PDE inhibitor and compositions therefor |
| CA2486350A1 (en) * | 2002-06-05 | 2003-12-24 | Kaneka Corporation | Process for producing optically active .alpha.-methylcysteine derivative |
| MXPA05001255A (es) * | 2002-08-02 | 2005-06-08 | Pharmacia Corp | Metodos para el tratamiento y prevencion de condiciones gastrointestinales. |
| AU2003269406A1 (en) * | 2002-11-01 | 2004-05-25 | Pharmacia & Upjohn Company Llc | Process for preparing s-(2-aminoethyl)-2-methyl-l-cysteine |
| US7544678B2 (en) | 2002-11-05 | 2009-06-09 | The Trustees Of Columbia University In The City Of New York | Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) |
| ES2280835T3 (es) * | 2002-12-19 | 2007-09-16 | Pharmacia Corporation | Formulacion no higroscopica que comprende un farmaco higroscopico. |
| WO2004064767A2 (en) * | 2003-01-23 | 2004-08-05 | Kahn Nighat N | Nitric oxide inducing agents |
| DE10308580B3 (de) * | 2003-02-27 | 2004-09-09 | Consortium für elektrochemische Industrie GmbH | Verfahren zur elektrophilen Substitution von Thiazolidinen oder Oxazolidinen |
| JP2007525165A (ja) | 2003-03-07 | 2007-09-06 | トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク | タイプ１ライアノジン受容体に基づく方法 |
| WO2004080955A1 (en) * | 2003-03-11 | 2004-09-23 | Pharmacia Corporation | S-[2-[1-iminoethyl)amino]ethyl]-2-methyl-l-cysteine maleate crystalline salt |
| MXPA05009779A (es) * | 2003-03-11 | 2005-10-26 | Pharmacia Corp | Sal cristalina de salicilato de s-[2-[(1-iminoetil)amino]etil]-2-metil-l-cisteina monohidrato. |
| MXPA05009244A (es) * | 2003-03-11 | 2005-10-19 | Pharmacia Corp | Procedimientos para la eliminacion selectiva de contraiones de compuestos y compuestos derivados de esos procedimientos. |
| WO2004080954A1 (en) * | 2003-03-11 | 2004-09-23 | Pharmacia Corporation | S-[2-[(1-iminoethyl)amino]ethyl]-2-methyl-l-cysteine maleate form ii crystalline salt |
| MXPA05008674A (es) * | 2003-03-11 | 2005-10-18 | Pharmacia Corp | Sal cristalina clorhidrato maleato de s-[2-[(1-iminoetil)amino]etil]-2-metil-l-cisteina. |
| US20040186046A1 (en) * | 2003-03-17 | 2004-09-23 | Pfizer Inc | Treatment of type 1 diabetes with PDE5 inhibitors |
| US7208631B2 (en) * | 2003-04-08 | 2007-04-24 | Mitsubishi Gas Chemical Company, Inc. | 2-alkylcysteinamide or salt thereof, process for producing these, and use of these |
| DE602004023534D1 (de) * | 2003-11-18 | 2009-11-19 | Mitsubishi Gas Chemical Co | Verfahren zur herstellung von optisch aktivem 2-alkylcystein, derivate davon und herstellungsverfahren |
| US8710045B2 (en) | 2004-01-22 | 2014-04-29 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the ryanodine receptors |
| US20060154981A1 (en) * | 2005-01-12 | 2006-07-13 | Alcon, Inc. | Method of reducing intraocular pressure and treating glaucoma |
| US7704990B2 (en) | 2005-08-25 | 2010-04-27 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the RyR receptors |
| EP1986656A4 (en) * | 2006-02-02 | 2012-05-16 | Univ South Florida | WITHACNISTINE COMPOUNDS FOR THE TREATMENT OF CANCER |
| WO2007103970A2 (en) * | 2006-03-07 | 2007-09-13 | Endacea, Inc. | Compositions and methods for treating respiratory disorders |
| US20090186854A1 (en) * | 2006-03-23 | 2009-07-23 | Meditor Pharmaceuticals Ltd. | S-alkylisothiouronium derivatives for the treatment of inflammatory diseases |
| US7820689B2 (en) * | 2006-08-10 | 2010-10-26 | Hua-Lin Wu | Methods and compositions for preventing or treating cardiovascular disease |
| CN101758337B (zh) | 2009-12-03 | 2012-02-15 | 湖南阿斯达生化科技有限公司 | 一种助焊剂用非卤素活性剂 |
| US10745467B2 (en) | 2010-03-26 | 2020-08-18 | The Trustees Of Dartmouth College | VISTA-Ig for treatment of autoimmune, allergic and inflammatory disorders |
| US20150231215A1 (en) | 2012-06-22 | 2015-08-20 | Randolph J. Noelle | VISTA Antagonist and Methods of Use |
| EP2552947A4 (en) | 2010-03-26 | 2013-11-13 | Dartmouth College | VISTA REGULATORY T CELL MEDIATOR PROTEIN, VISTA BINDING ACTIVE SUBSTANCES AND USE THEREOF |
| US9293197B2 (en) | 2011-08-15 | 2016-03-22 | Lockheed Martin Corporation | Reconfigurable phase change material masks for electro-optical compressive sensing |
| US9890215B2 (en) | 2012-06-22 | 2018-02-13 | King's College London | Vista modulators for diagnosis and treatment of cancer |
| TWI705073B (zh) | 2012-06-22 | 2020-09-21 | 達特茅斯學院基金會 | 新穎之vista-ig構築體及vista-ig用於治療自體免疫、過敏及發炎病症之用途 |
| JP6368308B2 (ja) | 2012-09-07 | 2018-08-01 | トラスティーズ・オブ・ダートマス・カレッジ | 癌の診断および治療のためのｖｉｓｔａ調節剤 |
| US9340446B1 (en) | 2013-02-04 | 2016-05-17 | Lockheed Martin Corporation | Optical apparatus and method of forming a gradient index device |
| SG11201509022XA (en) | 2013-05-02 | 2015-12-30 | Api Corp | METHOD FOR PRODUCING α-SUBSTITUTED CYSTEINE OR SALT THEREOF OR INTERMEDIATE FOR SYNTHESIS OF α-SUBSTITUTED CYSTEINE |
| EP3043788B1 (en) * | 2013-09-13 | 2023-06-07 | Replicon Health OY | D-glyceric acid or dl-glyceric acid for use in the treatment of degeneration diseases related to aging |
| US11014987B2 (en) | 2013-12-24 | 2021-05-25 | Janssen Pharmaceutics Nv | Anti-vista antibodies and fragments, uses thereof, and methods of identifying same |
| RS63295B1 (sr) | 2013-12-24 | 2022-06-30 | Janssen Pharmaceutica Nv | Anti-vista antitela i fragmenti |
| JP6997619B2 (ja) | 2014-06-11 | 2022-01-17 | キャシー・エイ・グリーン | 液性免疫の抑制または増進のための、ｖｉｓｔａアゴニスト及びｖｉｓｔａアンタゴニストの使用 |
| US10437083B1 (en) | 2014-10-20 | 2019-10-08 | Lockheed Martin Corporation | Individually addressable infrared mask array |
| EP3226900A4 (en) | 2014-12-05 | 2018-09-19 | Immunext, Inc. | Identification of vsig8 as the putative vista receptor and its use thereof to produce vista/vsig8 modulators |
| CN107922497B (zh) | 2015-06-24 | 2022-04-12 | 詹森药业有限公司 | 抗vista抗体和片段 |
| GB201512635D0 (en) | 2015-07-17 | 2015-08-26 | Ucl Business Plc | Uses of therapeutic compounds |
| CN109069626A (zh) | 2016-02-12 | 2018-12-21 | 詹森药业有限公司 | 抗-vista(b7h5)抗体 |
| US11649283B2 (en) | 2016-04-15 | 2023-05-16 | Immunext, Inc. | Anti-human vista antibodies and use thereof |
| US9969647B2 (en) | 2016-05-17 | 2018-05-15 | Lockheed Martin Energy, Llc | Glass composites having a gradient index of refraction and methods for production thereof |
| US9908808B1 (en) | 2016-08-18 | 2018-03-06 | Lockheed Martin Corporation | Ternary glass materials with low refractive index variability |
| EP3398941A1 (en) | 2017-05-03 | 2018-11-07 | AXXAM S.p.A. | Heterocyclic p2x7 antagonists |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU636713B2 (en) | 1990-02-26 | 1993-05-06 | Merrell Dow Pharmaceuticals Inc. | Inhibitors of nitric oxide biosynthesis |
| US5132453A (en) | 1991-03-22 | 1992-07-21 | Cornell Research Foundation, Inc. | N6 -(hydrazinoiminomethyl)lysine and method of inhibiting nitric oxide formation in body |
| JP2648897B2 (ja) | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | ピリミジン誘導体 |
| GB9127376D0 (en) | 1991-12-24 | 1992-02-19 | Wellcome Found | Amidino derivatives |
| GB9203347D0 (en) | 1992-02-17 | 1992-04-01 | Wellcome Found | Hypolipidaemic compounds |
| DE4234867A1 (de) * | 1992-10-16 | 1994-04-21 | Degussa | Verfahren zur Herstellung von Aminoalkylhydantoin und Aminoalkyl-alpha-aminosäuren |
| JPH08503940A (ja) | 1992-11-27 | 1996-04-30 | ザ ウエルカム ファウンデーション リミテッド | 酵素阻害薬 |
| JPH08504798A (ja) | 1992-12-18 | 1996-05-21 | ザ ウエルカム ファウンデーション リミテッド | 酵素阻害薬としての，ピリミジン，ピリジン，プテリジノンおよびインダゾール誘導体 |
| DE4324088A1 (de) * | 1993-07-17 | 1995-01-19 | Hoechst Ag | Hochtemperatursupraleitende Massivkörper und Verfahren zu ihrer Herstellung |
| CN1077886C (zh) | 1993-10-21 | 2002-01-16 | G·D·瑟尔公司 | 用作一氧化一氮合酶抑制剂的脒基衍生物 |
| JPH09504524A (ja) | 1993-10-21 | 1997-05-06 | ジー．ディー．サール アンド カンパニー | 酸化窒素シンターゼ阻害剤として有用なアミジノ誘導体 |
| GB9405211D0 (en) | 1994-03-17 | 1994-04-27 | Deas Alexander R | Noise cancellation apparatus |
| ES2141347T3 (es) | 1994-03-24 | 2000-03-16 | Searle & Co | Amidino-derivados utiles como inhibidores de oxido nitrico sintasa. |
| SI0765308T1 (sl) * | 1994-06-15 | 2000-08-31 | The Wellcome Foundation Limited | Encimski inhibitorji |
| US5994391A (en) | 1994-09-13 | 1999-11-30 | G.D. Searle And Company | Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| US5684008A (en) | 1994-11-09 | 1997-11-04 | G. D. Searle & Co. | Aminotetrazole derivatives useful as nitric oxide synthase inhibitors |
| ES2206571T3 (es) | 1995-04-20 | 2004-05-16 | G.D. SEARLE & CO. | Agentes de amidino ciclico utiles como inhibidores de la oxido nitrico sintasa. |
| AU712995B2 (en) | 1995-05-10 | 1999-11-18 | G.D. Searle & Co. | Nitric oxide synthase inhibitors derived from cyclic amidines |
| GB9516709D0 (en) | 1995-08-15 | 1995-10-18 | Zeneca Ltd | Medicament |
| US5830917A (en) | 1995-09-11 | 1998-11-03 | G. D. Searle & Co. | L-N6 -(1-iminoethyl) lysine derivatives useful as nitric oxide synthase inhibitors |
| US5981511A (en) * | 1996-03-06 | 1999-11-09 | G.D. Searle & Co. | Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors |
| US5945408A (en) | 1996-03-06 | 1999-08-31 | G.D. Searle & Co. | Hydroxyanidino derivatives useful as nitric oxide synthase inhibitors |
| MY117948A (en) * | 1997-01-13 | 2004-08-30 | Glaxo Group Ltd | Nitride oxide synthase inhibitors. |
| WO1999029865A2 (en) | 1997-12-12 | 1999-06-17 | The Rockefeller University | A protein belonging to the tnf superfamily, nucleic acids encoding same, and methods of use thereof |
| PL343380A1 (en) | 1998-03-11 | 2001-08-13 | Searle & Co | Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors |
| GB9811599D0 (en) | 1998-05-30 | 1998-07-29 | Glaxo Group Ltd | Nitric oxide synthase inhibitors |
| DK1265859T3 (da) * | 2000-03-24 | 2006-05-01 | Pharmacia Corp | Amidinoforbindelser der er nyttige som nitrogenoxidsyntaseinhibitorer |
-
2001
- 2001-03-23 DK DK01920718T patent/DK1265859T3/da active
- 2001-03-23 PT PT01922636T patent/PT1265860E/pt unknown
- 2001-03-23 JP JP2001570616A patent/JP4205340B2/ja not_active Expired - Fee Related
- 2001-03-23 CA CA2402199A patent/CA2402199C/en not_active Expired - Fee Related
- 2001-03-23 DE DE60110902T patent/DE60110902T2/de not_active Expired - Lifetime
- 2001-03-23 MY MYPI20011391A patent/MY135721A/en unknown
- 2001-03-23 NZ NZ542734A patent/NZ542734A/en not_active IP Right Cessation
- 2001-03-23 NZ NZ520812A patent/NZ520812A/en not_active IP Right Cessation
- 2001-03-23 ZA ZA200206459A patent/ZA200206459B/en unknown
- 2001-03-23 JP JP2001570615A patent/JP4216502B2/ja not_active Expired - Fee Related
- 2001-03-23 AT AT01922636T patent/ATE295832T1/de active
- 2001-03-23 US US09/816,577 patent/US6403830B2/en not_active Expired - Lifetime
- 2001-03-23 US US09/816,575 patent/US6586474B2/en not_active Expired - Lifetime
- 2001-03-23 WO PCT/US2001/009433 patent/WO2001072703A1/en not_active Ceased
- 2001-03-23 CA CA2402436A patent/CA2402436C/en not_active Expired - Fee Related
- 2001-03-23 DE DE60116067T patent/DE60116067T2/de not_active Expired - Lifetime
- 2001-03-23 MX MXPA02009282A patent/MXPA02009282A/es active IP Right Grant
- 2001-03-23 CN CNB018070655A patent/CN1294117C/zh not_active Expired - Fee Related
- 2001-03-23 AU AU2001249415A patent/AU2001249415B2/en not_active Ceased
- 2001-03-23 EP EP01920718A patent/EP1265859B1/en not_active Expired - Lifetime
- 2001-03-23 AU AU4774501A patent/AU4774501A/xx active Pending
- 2001-03-23 NZ NZ532073A patent/NZ532073A/en not_active IP Right Cessation
- 2001-03-23 AR ARP010101388A patent/AR033359A1/es not_active Application Discontinuation
- 2001-03-23 ES ES01920718T patent/ES2256223T3/es not_active Expired - Lifetime
- 2001-03-23 WO PCT/US2001/009431 patent/WO2001072702A2/en not_active Ceased
- 2001-03-23 AT AT01920718T patent/ATE313525T1/de active
- 2001-03-23 EP EP01922636A patent/EP1265860B1/en not_active Expired - Lifetime
- 2001-03-23 AU AU4941501A patent/AU4941501A/xx active Pending
- 2001-03-23 GE GEAP200110668A patent/GEP20094625B/en unknown
- 2001-03-23 NZ NZ520813A patent/NZ520813A/en not_active IP Right Cessation
- 2001-03-23 DK DK01922636T patent/DK1265860T3/da active
- 2001-03-23 BR BR0109386-0A patent/BR0109386A/pt active Search and Examination
- 2001-03-23 KR KR1020027012229A patent/KR100835265B1/ko not_active Expired - Fee Related
- 2001-03-23 ES ES01922636T patent/ES2240445T3/es not_active Expired - Lifetime
- 2001-03-23 AU AU2001247745A patent/AU2001247745B2/en not_active Ceased
- 2001-05-29 TW TW090106982A patent/TWI294417B/zh not_active IP Right Cessation
-
2002
- 2002-08-13 ZA ZA200206455A patent/ZA200206455B/en unknown
- 2002-12-17 US US10/321,969 patent/US7102013B2/en not_active Expired - Fee Related
-
2004
- 2004-04-01 US US10/815,375 patent/US6914158B2/en not_active Expired - Lifetime
-
2005
- 2005-01-10 US US11/032,650 patent/US7196118B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003528852A5 (enExample) | ||
| RU2002107975A (ru) | Глюкопиранозилоксипиразольные производные, лекарственные композиции, содержащие эти производные, и промежуточные соединения для их получения | |
| JP2002508352A5 (ja) | ４(３)置換−４(３)−アミノメチル−（チオ）ピラン又はピペリジン誘導体（＝ガバペンチン類似体） | |
| RU2397168C2 (ru) | Производные тиофена в качестве ингибиторов снк 1 | |
| JP2005523922A5 (enExample) | ||
| JP2005506348A5 (enExample) | ||
| JP2006501295A5 (enExample) | ||
| JP2010508296A5 (enExample) | ||
| RU2008106058A (ru) | Производные пиридазинона в качестве агонистов рецептора тиреоидного гормона | |
| EP1797878A3 (en) | Benzothiazole derivatives | |
| RU2004104625A (ru) | Аналоги простагландинов в качестве агонистов рецептора ep4 | |
| JP2016509591A5 (enExample) | ||
| JP2010077141A5 (enExample) | ||
| JP2008509166A5 (enExample) | ||
| RU95120598A (ru) | Производные 10,11-метандибензосуберана, используемые в качестве хемосенсибилизующих агентов | |
| JP2007502806A5 (enExample) | ||
| JP2003506354A5 (enExample) | ||
| RU2005107314A (ru) | Пиримидопроизводные, характеризующиеся антипролиферативной активностью | |
| JP2020507589A5 (enExample) | ||
| JPH10279578A5 (enExample) | ||
| KR970014765A (ko) | 신경보호제를 이용한 이명의 치료 | |
| KR890005031A (ko) | L-도파유도체 또는 그의 산부가염, 그의 제조방법 및 그의 용도 | |
| JP2005508368A5 (enExample) | ||
| RU2004139050A (ru) | Производные 1-сульфонил-4-аминоалкоксииндола в качестве модуляторов 5-нт6 рецептора для лечения заболеваний цнс | |
| RU97113367A (ru) | Производные нейраминовой кислоты, их получение и применение в медицине |